The key to fighting the coronavirus outbreak lies in the application of supply-chain management principles, and the creation of a global, end-to-end network for partner collaboration in the healthcare industry.
Inspections of foreign drug manufacturers by the U.S. Food and Drug Administration have fallen in recent years despite increasing worry about the safety and quality of generic medications, congressional investigators said.
Until recently, the big worry associated with cyberattacks was data loss. The NotPetya strike shows how a few hundred lines of malicious code can bring a company to its knees.
Among the dangers are a decline in cross-border investment, disruption in the supply chain and decreased collaboration in fields like artificial intelligence, wireless technology and cancer research.
With greater reliance on trading partners, complex supply networks and customer demands, running an intelligent supply chain has never been more vital. Explore the value of linking direct spend sourcing with design, manufacturing and planning processes to build an intelligent digital supply chain.
The trade standoff between the U.S. and China has yet to seriously impact the pharmaceutical and life sciences industries. But as neither side shows signs of backing down, and tariffs continue to be levied on virtually every segment, those sectors are preparing for a major supply-chain disruption.
